Given the high prevalence and early-onset of PCC/PGL for those with VHL, guidelines recommend screening for PCC/PGL starting at age 5 with annual lifelong biochemical testing (VHL Alliance 2015, Rednam et al. 2017). This evidence concerns the gene VHL and adrenal gland pheochromocytoma.